Xiangming Hu
-
- Ubiquitin and proteasome pathways 9
- Protein Degradation and Inhibitors 9
- Signaling Pathways in Disease 5
- Histone Deacetylase Inhibitors Research 4
- Epigenetics and DNA Methylation 3
-
- Immune cells in cancer 4
-
- Peptidase Inhibition and Analysis 4
-
- Advanced Battery Materials and Technologies 3
- Partner nations
- ChinaUnited StatesUkraine
In The Last Decade
Xiangming Hu
19 papers receiving 527 citations
Peers
Comparison fields: 5 of 72
- Molecular Biology 406
- Immunology 109
- Hematology 54
- Cancer Research 64
- Virology 18
Countries citing papers authored by Xiangming Hu
This map shows the geographic impact of Xiangming Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangming Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangming Hu more than expected).
Fields of papers citing papers by Xiangming Hu
This network shows the impact of papers produced by Xiangming Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangming Hu. The network helps show where Xiangming Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiangming Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 24 | |
| 7 | 2023 | 13 | |
| 8 | 2022 | 54 | |
| 9 | 2021 | 23 | |
| 10 | 2021 | 24 | |
| 11 | 2020 | 17 | |
| 12 | 2020 | 20 | |
| 13 | 2020 | 14 | |
| 14 | 2018 | 61 | |
| 15 | 2017 | 67 | |
| 16 | 2017 | 38 | |
| 17 | 2016 | 44 | |
| 18 | 2014 | 39 | |
| 19 | 2014 | 3 | |
| 20 | 2013 | 39 |
About Xiangming Hu
Xiangming Hu is a scholar working on Immunology, Automotive Engineering and Molecular Biology, having authored 22 papers that have together received 532 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (9 papers), Protein Degradation and Inhibitors (9 papers), Signaling Pathways in Disease (5 papers), Peptidase Inhibition and Analysis (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Immune cells in cancer (4 papers), Advanced Battery Materials and Technologies (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Molecular Biology (406 citations), Immunology (109 citations) and Hematology (54 citations). Xiangming Hu has collaborated with scholars based in China, United States and Ukraine. Frequent co-authors include Lin‐Feng Chen, Jinjing Chen, Xingchen Dong, Ruichuan Chen, Dun Pan, Li Guo, Dan Hu, Kunqi Chen, Runzhong Liu and Yan Bao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.